Free Press Release Submission




Send to a Friend "Human Cloning Can Help the Paralyzed Walk Again"


Medical research brings us closer to the day when human cloning can help the paralyzed walk again.

You will send the story Human Cloning Can Help the Paralyzed Walk Again to a specified friend:

Your Name:

Your E-mail:


Your Friend's Name:

Your Friend's E-mail:

Medical research brings us closer to the day when human cloning can help the paralyzed walk again.
The Human Cloning Foundation yesterday said that human cloning research took a significant step forward with recent findings that human embryonic stem cells could help rats with spinal cord damage walk again.

“We are coming closer to the day when human cloning can help the paralyzed walk again,” said David Madrigal, HCF spokesman.

Embryonic stem cells are formed from a one-cell DNA clone of the human who needs treatment. The cell is allowed to divide about six times and then the stem cells are harvested.

On Wednesday, the Journal of Neuroscience published a study saying human embryonic stem cells could help paralyzed rats walk again when used within a week of the spinal injury. The rats’ walking ability improved two months later.

However, the study showed that rats that were treated 10 months after the injury had no benefit.

Madrigal said the study is a “breakthrough” and is among the first evidence that human cloning can help the crippled walk again.

The research study was funded by Geron Corporation, based in Menlo
Park, California.

People can reach the HCF on www.humancloning.org. The Foundation is currently soliciting comments from human cloning advocates for a position paper for the U.S. Senate, which is considering legislation on human cloning.

Contact person : Mr. David Madrigal
david@humancloning.org.com

Release Archive | SEO Cornwall | Press Release Topics | Social Media Mafia | Social Media Business | TOS
Property Investment
Web site engine's code is Copyright © 2003 by PHP-Nuke. All Rights Reserved. PHP-Nuke is Free Software released under the GNU/GPL license.
Page Generation: 0.117 Seconds. -